Candidemia in Finland, 1995-1999

Emerging Infectious Diseases

Volumn 9, Issue 8, 2003, Pages 985-990

  Poikonen, Eira ^a   Lyytikäinen, Outi ^b   Anttila, Veli Jukka ^c   Ruutu, Petri ^b  

^a PEIJAS HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; DISEASE PREDISPOSITION; FATALITY; FINLAND; GASTROINTESTINAL SURGERY; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; INDWELLING CATHETER; NONHUMAN; POPULATION RESEARCH; SOLID TUMOR;

EID: 0042626532     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0908.030069     Document Type: Article

References (39)

1. Harvey RL, Myers JP. Nosocomial fungemia in a large community teaching hospital. Arch Intern Med 1987;147:2117-20.
2. Pittet D, Wenzel RP. Nosocomial bloodstream infections. Arch Intern Med 1995;155:1177-84.
3. Fisher-Hoch SP, Hutwagner L. Opportunistic candidiasis: an epidemic of the 1980s. Clin Infect Dis 1995;21:897-904.
4. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998;17:504-8.
5. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia. Arch Intern Med 1988;148:2642-5.
6. Beck-Sagué CM, Jarvis WR, the National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993;167:1247-51.
7. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on candida species. Clin Infect Dis 1995;20:1526-30.
8. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial bloodstream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn Microbiol Infect Dis 1998;31:327-32.
9. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999;29:239-44.
10. Vincent J-L, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin M-H, et al. The prevalence of nosocomial infection in intensive care units in Europe. JAMA 1995;274:639-44.
11. Voss A, Kluytmans JAJW, Koeleman JGM, Spanjaard L, Vandenbroucke-Grauls CMJE, Verbrugh HA, et al. Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis 1996;15:909-12.
12. Hope W, Morton A, Eisen DP. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. J Hosp Infect 2002;50:56-65.
13. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996;9:499-511.
14. Borg-von Zeppelin M, Eiffert H, Kann M, Rüchel R. Changes in the spectrum of fungal isolates: results from clinical specimens gathered in 1987/88 compared with those in 1991/92 in the university of Göttingen, Germany. Mycoses 1993;36:247-53.
15. Nguyen MH, Peacock JE, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996;100:617-23.
16. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997;24:1122-8.
17. Pfaller MA, Jones RN, Doern GV, Fluit AC, Verhoef J, Sader HS, et al. International surveillance of bloodstream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. Diagn Microbiol Infect Dis 1999;35:19-25.
18. Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BS, Stephens DS, et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999;29:1164-70.
19. Petri MG, König J, Moecke HP, Gramm HJ, Barkow H, Kujath P, et al. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Intensive Care Med 1997;23:317-25.
20. Pittet D, Harbarth S, Ruef C, Francioli P, Sudre P, Pétignat C, et al. Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland. Infect Control Hosp Epidemiol 1999;20:37-42.
21. Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Vandercam B, et al. Candidemia in cancer patients: a prospective multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999;28:1071-9.
22. Luzzati R, Amalfitano G, Lazzarini L, Soldani F, Bellino S, Solbiati M, et al. Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. Eur J Clin Microbiol Infect Dis 2000;19:602-7.
23. Richet H, Roux P, Des Champs C, Esnault Y, Andremont A, the French Candidemia Study Group. Candidemia in French hospitals: incidence rates and characteristics. Clin Microbiol Infect 2002;8:405-12.
24. Tortorano AM, Biraghi E, Astolfi A, Ossi C, Tejada M, Farina C, et al. European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. J Hosp Infect 2002;51:297-304.
25. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis 1998;27:1138-47.
26. Diekema DJ, Messer SA, Brueggemans AB, Coffman SL, Doern GV, Herwaldt LA, et al. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002;40:1298-302.
27. Ásmundsdóttir LR, Erlensdóttir H, Gottfredsson M. Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol 2002;40:3489-92.
28. Sandven P, Bevanger L, Digranes A, Gaustad P, Haukland HH, Steinbakk M, et al. Constant low rate of fungemia in Norway, 1991 to 1996. J Clin Microbiol 1998;36:3455-9.
29. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128-40.
30. Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WJR, Horan T, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991;91(Suppl):86S-9S.
31. Lyytikäinen O, Lumio J, Sarkkinen H, Kolho E, Kostiala A, Ruutu P. Nosocomial bloodstream infections in Finnish hospitals during 1999-2000. Clin Infect Dis 2002;35:e14-9.
32. Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study. J Infect Dis 1995;171:1545-52.
33. Blumberg HM, Jarvis WR, Soucie JM, Edwards JM, Patterson JE, Pfaller MA, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis 2001;33:177-86.
34. Singh N. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. Clin Infect Dis 2001;33:1692-6.
35. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274-7.
36. National Public Health Institute. Infectious diseases in Finland 2000. Publications of the National Health Institute. 2001. [Cited 22 November 2002.] Available from: URL:http://www.ktl.fi/en/publications
37. Petrosillo N, Viale P, Nicastri E, Arici C, Bombana E, Caella A, et al. Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors. Clin Infect Dis 2002;34:677-85.
38. Launay O, Lortholary O, Bouges-Michel C, Jarrousse B, Bentata M, Guillevin L. Candidemia: a nosocomial complication in adults with late-stage AIDS. Clin Infect Dis 1998;26:1134-42.
39. Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based study. Clin Infect Dis 1997;24:1068-78.